Cargando…
JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells
Platinum chemotherapeutics are widely used to treat solid malignant tumors, including gastric cancer (GC). Drug resistance to platinum compounds may result in cancer relapse and decreased survival. The identification and development of novel agents to reactivate apoptosis pathways in platinum-resist...
Autores principales: | Wang, Q, Chen, Q, Zhu, L, Chen, M, Xu, W, Panday, S, Wang, Z, Li, A, Røe, O D, Chen, R, Wang, S, Zhang, R, Zhou, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541709/ https://www.ncbi.nlm.nih.gov/pubmed/28671676 http://dx.doi.org/10.1038/oncsis.2017.57 |
Ejemplares similares
-
JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
por: Xu, W, et al.
Publicado: (2014) -
Synergistic Role between p53 and JWA: Prognostic and Predictive Biomarkers in Gastric Cancer
por: Liu, Xin, et al.
Publicado: (2012) -
Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery
por: Ding, Kun, et al.
Publicado: (2022) -
JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12
por: Liang, Yan, et al.
Publicado: (2021) -
ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients
por: Lu, J, et al.
Publicado: (2013)